Pharvaris Highlights Properties of Deucrictibant in Data Presentations at Recent Congresses

PHVS Stock  USD 21.90  0.46  2.06%   
Slightly above 62% of Pharvaris' investor base is looking to short. The analysis of the overall investor sentiment regarding Pharvaris BV suggests that many traders are alarmed. Pharvaris' investing sentiment can be driven by a variety of factors including economic data, Pharvaris' earnings reports, geopolitical events, and overall market trends.
  
Deucrictibant substantially resolved symptoms of an HAE attack in 78.6 percent participants within 24 hoursHigh treatment satisfaction of deucrictibant driven by favorable effectiveness subdomain score compared to placebo ZUG,

Read at benzinga.com
benzinga news
  

Pharvaris Investor Sentiment by Other News Outlets

Investor sentiment, mood or attitude towards Pharvaris can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.

Pharvaris Fundamental Analysis

We analyze Pharvaris' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Pharvaris using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Pharvaris based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Short Ratio

Short Ratio Comparative Analysis

Pharvaris is currently under evaluation in short ratio category among its peers. Short Ratio is typically used by traders and speculators to identify trends in current market sentiment for a particular equity instrument. In its simple terms this ratio shows how many days it will take all current short sellers to cover their positions if the price of a stock begins to rise.

Pharvaris BV Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Pharvaris stock to make a market-neutral strategy. Peer analysis of Pharvaris could also be used in its relative valuation, which is a method of valuing Pharvaris by comparing valuation metrics with similar companies.

Peers

Pharvaris Related Equities

ANTXAN2 Therapeutics   21.90   
0%
100.0%
GLUEMonte Rosa   13.72   
0%
62.0%
MNOVMediciNova   2.99   
0%
13.0%
IKNAIkena Oncology   2.37   
0%
10.0%
STOKStoke Therapeutics   1.68   
0%
7.0%
HOWLWerewolf Therapeutics   1.52   
0%
6.0%
PMVPPmv Pharmaceuticals   1.25   
0%
5.0%
RZLTRezolute   1.00   
0%
4.0%
ANEBAnebulo Pharmaceuticals   0.70   
0%
3.0%
DSGNDesign Therapeutics   0.50   
0%
2.0%
MOLNMolecular Partners   0.17   
1.0%
0%
PEPGPepGen   0.98   
4.0%
0%
ELYMEliem Therapeutics   1.30   
5.0%
0%
TYRATyra Biosciences   2.00   
9.0%
0%
JANXJanux Therapeutics   2.54   
11.0%
0%
MLYSMineralys Therapeutics,   2.59   
11.0%
0%

Additional Tools for Pharvaris Stock Analysis

When running Pharvaris' price analysis, check to measure Pharvaris' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pharvaris is operating at the current time. Most of Pharvaris' value examination focuses on studying past and present price action to predict the probability of Pharvaris' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pharvaris' price. Additionally, you may evaluate how the addition of Pharvaris to your portfolios can decrease your overall portfolio volatility.